Frontier Bio (FBIO) Bolstering it’s Warchest.
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
NEW YORK, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Common Stock: Nasdaq: FBIO)...
Is True Nature (TNTY) $0.04, Nearing a Breakout?
After a Tough Year, a Series of Development Releases Appears to Have Halted True Natures Downtrend and Move to a Possible Breakout.
Only time...
True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.
Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.
"Been there, done that -...
Biotech’s Turning Up…
Biotech Sector Gains Near 10% in Past Month, After Biogen (BIIB) Reports Breaking News.
We keep telling investors (for 40+ years) it's not stock picking...
Dyadic (DYAI) Highlights.
"In just over a year and a half we have entered into over 15 proof of concept collaborations for both human and animal health...
Mustang Bio (MBIO) Highlights.
"With a strong balance sheet and the continued advancement of our gene therapy and CAR T programs, we are well-positioned to execute on our...
Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2...
We are going through some of our very old 'incubator files' back from when we ran the Incubator Stock Review, a spinoff from the...
What We’re Watching.
“Biotech, Beverages and Bears - Oh My!”
— Daniel K. McMahon
Headlines this week from winners in the past and just maybe, from some major winners...
Medtech Incubator in Final Stages of Launch.
TrueNature (TNTY) Has Spent the Past Year Gearing Up. News of a Launch and First Incubation Effort Could be Around the Corner and Attract...
Investor Presentation Slides From Dyadic (DYA) $6.40.
Really, How Do We Do It?
Live Short Term Chart
INVESTOR PRESENTATION
LONGER TERM CHART
Client, see published reports for disclosure and disclaimer details.